domingo, 3 de marzo de 2024

Repotrectinib Expands Treatment Options for Lung Cancers with ROS1 Fusions

https://www.cancer.gov/news-events/cancer-currents-blog/2024/repotrectinib-lung-cancer-ros1?cid=eb_govdel

No hay comentarios:

Publicar un comentario